Biochemical Reagent
-
BA5288 AZD-5069Summary: AZD-5069 is an effective antagonist. - BA5289 SX-682Summary: SX-682 is an orally effective alteration inhibitor.
- BA5290 ACT-1004-1239Summary: ACT-1004-1239 is a potent, selective, oral antagonist.
- BA5291 LadarixinSummary: Ladarixin (DF2156A free base) is an orally active, non-competitive alterative inhibitor.
- BA5292 NBI-74330Summary: NBI-74330 is a potent antagonist that inhibits the specific binding of (I)CXCL10 and (I)CXCL11.
- BA5293 DanirixinSummary: Danirixin is a selective, reversible antagonist.
- BA5294 LY2510924Summary: LY2510924 is a potent, selective antagonist; prevents SDF-1 from binding CXCR4.
- BA5295 MSX-122Summary: MSX-122 is an orally available partial antagonist that inhibits interactions with values of approximately 10 nM.
- BA5296 CXCR2-IN-2Summary: CXCR2-IN-2 is a selective, blood-brain barrier-crossing, orally bioavailable antagonist (5.2nM/1nM in β-arrestin and Tango assays, respectively).
- BA5297 PentixaforSummary: Pentixafor is a targeted peptide.